Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.

Echavidre W, Durivault J, Gotorbe C, Blanchard T, Pagnuzzi M, Vial V, Raes F, Broisat A, Villeneuve R, Amblard R, Garnier N, Ortholan C, Faraggi M, Serrano B, Picco V, Montemagno C

Open source

DOI: 10.1158/2767-9764.crc-23-0298
Published: 2023 Dec 7
Container: Cancer research communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-23-0298,
  title = {Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.},
  author = {Echavidre W and Durivault J and Gotorbe C and Blanchard T and Pagnuzzi M and Vial V and Raes F and Broisat A and Villeneuve R and Amblard R and Garnier N and Ortholan C and Faraggi M and Serrano B and Picco V and Montemagno C},
  year = {2023},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-23-0298},
  url = {https://doi.org/10.1158/2767-9764.crc-23-0298}
}

RIS

TY  - JOUR
TI  - Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.
AU  - Echavidre W
AU  - Durivault J
AU  - Gotorbe C
AU  - Blanchard T
AU  - Pagnuzzi M
AU  - Vial V
AU  - Raes F
AU  - Broisat A
AU  - Villeneuve R
AU  - Amblard R
AU  - Garnier N
AU  - Ortholan C
AU  - Faraggi M
AU  - Serrano B
AU  - Picco V
AU  - Montemagno C
PY  - 2023
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-23-0298
UR  - https://doi.org/10.1158/2767-9764.crc-23-0298
ER  -

APA

W, E., J, D., C, G., T, B., M, P., V, V., F, R., A, B., R, V., R, A., N, G., C, O., M, F., B, S., V, P., & C, M. (2023). Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-23-0298

Source records

pubmed · retrieved 2026-09-27T01:27:32.494Z
europe-pmc · retrieved 2026-09-27T01:27:32.321Z
hal · retrieved 2026-09-27T01:27:32.345Z